NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysesMontserrat García‐Closas, Nathaniel Rothman, Stephen J. Chanock et al.|The Lancet|2005Cited by 631
Correction: Corrigendum: Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain studyGemma Ibáñez-Sanz, Vı́ctor Moreno, Anna Díez-Villanueva et al.|Scientific Reports|2017Cited by 505
Lung cancer and socioeconomic status in a pooled analysis of case-control studiesJan Hovanec, Thomas Behrens, Jack Siemiatycki et al.|PLoS ONE|2018Cited by 167
Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer ConsortiumMiguel García-Pardo, Geoffrey Liu, Amy Chang et al.|Journal of Thoracic Oncology|2022Cited by 26
Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controlsXiaoyu Zhao, Juncheng Dai, Meiqi Yang et al.|Cancer|2023Cited by 8